CD8A and neoplasm: Preclinical investigations further demonstrate that nanoparticles targeted toward tumor-associated microbes can effectively reprogram local immunity by promoting dendritic cell maturation (CD80+, CD86+ expression), enhancing cytotoxic CD8+ T-cell infiltration, and augmenting the therapeutic efficacy of checkpoint blockade [143,152,153].